Article Text
PDF
Abstract
A 69-year-old retired miner with stage 4 non-small-cell lung cancer presented with a 2-month history of obstructive liver function tests following nivolumab immunotherapy. His case had not responded to high dose prednisolone or mycophenolate and he was admitted for investigation. MR cholangiopancreatography demonstrated areas of intrahepatic biliary tree beading and stricturing, in keeping with sclerosing cholangitis. Prednisolone and mycophenolate were stopped and ursodeoxycholic acid commenced with subsequent partial improvement of the patient’s liver function tests.
- lung cancer (oncology)
- unwanted effects / adverse reactions
- radiology
- liver disease
Statistics from Altmetric.com
Footnotes
Contributors ST was the primary author of this manuscript, and was responsible for obtaining patient consent, collation of images and data, literature review, drafting and submission of the manuscript. VM contributed to and reviewed the manuscript from an oncology perspective. HL supervised and approved the final manuscript for submission, in addition to contributing to and reviewing it from a hepatology perspective.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.